Mitsubishi UFJ Asset Management Co. Ltd. Has $160.05 Million Holdings in HCA Healthcare, Inc. $HCA

Mitsubishi UFJ Asset Management Co. Ltd. lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 340,253 shares of the company's stock after selling 2,981 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.15% of HCA Healthcare worth $160,052,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Cerity Partners LLC grew its position in shares of HCA Healthcare by 13.1% during the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company's stock worth $18,719,000 after buying an additional 5,092 shares during the period. National Pension Service grew its position in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company's stock worth $267,051,000 after buying an additional 17,531 shares during the period. Savant Capital LLC grew its position in shares of HCA Healthcare by 37.7% during the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company's stock worth $1,938,000 after buying an additional 1,246 shares during the period. Sector Gamma AS grew its position in shares of HCA Healthcare by 36.0% during the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company's stock worth $4,638,000 after buying an additional 2,883 shares during the period. Finally, Nordea Investment Management AB grew its position in shares of HCA Healthcare by 11.2% during the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company's stock worth $507,393,000 after buying an additional 108,849 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the firm's stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares of the company's stock, valued at $4,721,924.61. This trade represents a 16.06% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president directly owned 44,379 shares of the company's stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,714 shares of company stock valued at $7,050,460 in the last ninety days. 1.50% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HCA. Sanford C. Bernstein cut their target price on HCA Healthcare from $541.00 to $503.00 and set a "market perform" rating on the stock in a report on Tuesday, April 28th. Wells Fargo & Company cut their target price on HCA Healthcare from $481.00 to $436.00 and set an "equal weight" rating on the stock in a report on Monday, April 27th. Wall Street Zen cut HCA Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Cantor Fitzgerald reiterated an "overweight" rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Finally, Mizuho increased their target price on HCA Healthcare from $540.00 to $585.00 and gave the stock an "outperform" rating in a report on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $517.82.

HCA Healthcare Trading Up 0.4%

Shares of NYSE:HCA opened at $430.45 on Thursday. The stock's fifty day simple moving average is $493.48 and its two-hundred day simple moving average is $486.55. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The stock has a market cap of $95.49 billion, a PE ratio of 14.80, a price-to-earnings-growth ratio of 1.36 and a beta of 1.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter last year, the business posted $6.45 earnings per share. HCA Healthcare's revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.